Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Jakšić, Hrvoje
DOB:	23-JUL-1986 (Age: 39)
Gender:	male
Address:	Kirchenallee 21 94557 Niederalteich (Germany)
ID:	5550-400599-6

Report
Date:	05-SEP-2023

Laboratory

Requested by
ASKLEPIOS Klinik Schaufling Hausstein 2 94571 Schaufling (Germany)

Specimen
Collected:	04-SEP-2023

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	04 Sep 2023	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	7.2 H	4 - 6	%
Glucose [Mass/volume] in Blood	90.2	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	13.6	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	1.1	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.0	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	141.3	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.7	3.5 - 5.3	mmol/L
Chloride [Moles/volume] in Blood	108.6	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	20.9 L	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	188.5	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	119.5	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	107.0	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	57.6	40 - 100	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	12.4	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c (7.2%), indicating suboptimal long-term glycemic control consistent with diabetes. All other parameters, including renal function, electrolytes, lipid profile, and urine microalbumin/creatinine ratio, are within normal limits except for mildly decreased total CO₂, which may suggest mild metabolic acidosis. Recommend optimizing diabetes management and monitoring acid-base status if clinically indicated.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated HbA1c (7.2%), indicating suboptimal long-term glycemic control consistent with diabetes. All other parameters, including renal function, electrolytes, lipid profile, and urine microalbumin/creatinine ratio, are within normal limits except for mildly decreased total CO₂, which may suggest mild metabolic acidosis. Recommend optimizing diabetes management and monitoring acid-base status if clinically indicated.